Trial Site Detail
Drug: |
INBRX-109 + Temozolomide |
|||
|---|---|---|---|---|
Trial: |
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
University of Chicago5841 S. Maryland Ave |
Principal Investigator: |
Hedy Kindler, MD |
|---|---|
Contact: |
Bianca Hill 773-834-1472 bhill22@medicine.bsd.uchicago.edu Buerkley Rose 773-834-4002 brose@bsd.uchicago.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Chicago Website: |
https://med-www02.bsd.uchicago.edu/crc_web/SR/internet/DiseaseSites.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.